Related Links
ARALAST NP Therapy
Choose a therapy that offers support for your patients.
ARALAST NP AATmosphere Program
Support for Alphas and families from the ARALAST NP AATmosphere program.
Easy Start Sample Program
Baxter is offering Alpha-1 patients (who have not previously used ARALAST NP therapy) and their physicians the opportunity to receive up to a two-week sample supply for a no-charge trial.
To initiate the process to receive a complimentary two-week trial sample of ARALAST NP therapy, please call 1-866-ARALAST (272-5278).
You can have confidence in Baxter's...
- Commitment to a reliable supply of ARALAST NP therapy
- Distribution of ARALAST NP therapy through Specialized Pharmacy Providers who provide comprehensive in-home care
- Support for the Alpha-1 community through continued AAT deficiency research
- Patient Assistance programs, including Baxter's Alpha-1 Security Program
ARALAST NP [Alpha1-Proteinase Inhibitor (Human)]
ARALAST NP is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST NP is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
The effect of augmentation therapy with ARALAST NP on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.
Please review the Important Risk Information and the Full Prescribing Information
Please review the Important Risk Information and the Full Prescribing Information
